P06737 (PYGL_HUMAN) Homo sapiens (Human)

Glycogen phosphorylase, liver form UniProtKBInterProSTRINGInteractive Modelling

847 aa; Sequence (Fasta) ; (Isoform 2); 3 identical sequences: Pan troglodytes: H2Q8A4, A0A6D2XQK0; Pan paniscus: A0A2R9BC33

Available Structures

19 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, …homo-4-mer21-831
NBG;PLP;700;CFF;MRD;
Assess
Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, a…homo-4-mer23-832
NBG;PLP;700;URC; 10×MRD;
Assess
Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine…homo-4-mer23-831
NBG;PLP;700;RBF;MRD;
Assess
Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, …homo-4-mer23-831
NBG;PLP;700;CFF;
Assess
Human liver glycogen phosphorylase- GL complexhomo-2-mer5-839
PLP;
Assess
HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH AMPhomo-2-mer6-839
GLC;AMP;PLP;
Assess
Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261homo-2-mer13-831
NBG;PO4;PLP;CFF;26B;MPD;MES;
Assess
Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055homo-2-mer13-831
NBG;PLP;CFF;055;MPD;MES;
Assess
Crystal structure of glycogen phophorylase complexed with an anthranilimide based inhibitor GSK254homo-2-mer13-831
NBG;PLP;CFF;25D;MPD;MES;
Assess
Human Liver Glycogen Phosphorylase A complexed with Chloroindoloyl glycine amidehomo-2-mer24-839
NBG;PLP;288;
Assess
Glycogen Phosphorylase Inhibitorshomo-2-mer24-832
GLC;IHU;PLP;
Assess
HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-526,423homo-2-mer23-831
NBG;CP4;PLP;MPD;
Assess
HUMAN LIVER GLYCOGEN PHOSPHORYLASE COMPLEXED WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINEhomo-2-mer24-832
NBG;PLP;
Assess
Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)ph…homo-2-mer23-831
GLC;MES;PLP;A46;MPD;
Assess
Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423homo-2-mer24-832
NBG;PLP;AVD;
Assess
Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688homo-2-mer24-832
NBG;PO4;PLP;AVE;MES;
Assess
Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865homo-2-mer24-832
NBG;PLP;AVF;
Assess
HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-403,700homo-2-mer24-831
NBG;PLP;700;MPD;
Assess
Cryo-EM structure of human liver glycogen phosphorylasehomo-2-mer25-829
PLP;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ati.1.Ahomo-2-mer0.8724-832
GLC;IHU;PLP;100.00
Assess
1axr.1.Bhomo-2-mer0.8615-840
HTP;80.45
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22ati.1.Ahomo-2-mer0.8424-798
GLC;IHU;100.00
Assess
Isoform 21axr.1.Bhomo-2-mer0.8315-806
HTP;80.25
Assess